tiprankstipranks
Nascent Pharma Holdings (NASC)
OTHER OTC:NASC
US Market
NASC
Nascent Pharma Holdings
RESEARCH TOOLSreports
Want to see NASC full AI Analyst Report?

Nascent Pharma Holdings (NASC) Income Statement

28 Followers

Nascent Pharma Holdings Income Statement

Last quarter (Q3 2024), Nascent Pharma Holdings's total revenue was $15.27K, a decrease of -96.36% from the same quarter last year. In Q3, Nascent Pharma Holdings's net income was $-3.26M. See Nascent Pharma Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Mar 21
Total Revenue
$ 0.00$ 2.16M$ 6.69M$ 4.60M$ 1.71M
Gross Profit
$ -742.32K$ 358.70K$ 2.61M$ 2.99M$ 1.43M
Operating Expenses
$ 4.02M$ 7.85M$ 16.78M$ 13.26M$ 8.97M
Depreciation and Amortization
$ 343.61K$ 1.40M$ 1.43M$ 542.35K$ 783.30K
EBITDA
$ -7.65M$ -5.82M$ -12.59M$ -9.52M$ -7.16M
Operating Income
$ -4.76M$ -7.49M$ -14.17M$ -10.27M$ -7.54M
Other Income/Expenses
$ -5.02M$ -2.24M$ -755.24K$ -1.90M$ -1.34M
Pretax Income
$ -9.78M$ -9.73M$ -14.92M$ -12.17M$ -8.88M
Net Income
$ -10.20M$ -9.74M$ -14.92M$ -12.17M$ -8.88M
Per Share Metrics
Basic EPS
$ -0.17$ -0.77$ -4.18$ -9.06$ -37.68
Diluted EPS
$ -0.17$ -0.77$ -4.18$ -9.06$ -37.68
Weighted Average Shares Outstanding
 58.37M 12.59M 3.57M 1.34M 235.65K
Weighted Average Shares Outstanding (Diluted)
 58.37M 12.59M 3.57M 1.34M 235.65K
Currency in USD

Nascent Pharma Holdings Earnings and Revenue History